154 related articles for article (PubMed ID: 34164689)
21. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
22. NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.
Fritchie KJ; Jin L; Rubin BP; Burger PC; Jenkins SM; Barthelmeß S; Moskalev EA; Haller F; Oliveira AM; Giannini C
J Neuropathol Exp Neurol; 2016 Mar; 75(3):263-71. PubMed ID: 26883114
[TBL] [Abstract][Full Text] [Related]
23. Pituicytoma: Review of commonalities and distinguishing features among TTF-1 positive tumors of the central nervous system.
El Hussein S; Vincentelli C
Ann Diagn Pathol; 2017 Aug; 29():57-61. PubMed ID: 28807344
[TBL] [Abstract][Full Text] [Related]
24. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
25. Successful Use of BRAF/MEK Inhibitors as a Neoadjuvant Approach in the Definitive Treatment of Papillary Craniopharyngioma.
Khaddour K; Chicoine MR; Huang J; Dahiya S; Ansstas G
J Natl Compr Canc Netw; 2020 Dec; 18(12):1590-1595. PubMed ID: 33285519
[TBL] [Abstract][Full Text] [Related]
26. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
Yue Q; Yu Y; Shi Z; Wang Y; Zhu W; Du Z; Yao Z; Chen L; Mao Y
J Neurosurg; 2018 Jul; 129(1):27-34. PubMed ID: 28984520
[TBL] [Abstract][Full Text] [Related]
27. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
Robinson LC; Santagata S; Hankinson TC
Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
[TBL] [Abstract][Full Text] [Related]
28. Proton therapy for tumors of the base of the skull.
Noel G; Gondi V
Chin Clin Oncol; 2016 Aug; 5(4):51. PubMed ID: 27558252
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.
Calvanese F; Jacquesson T; Manet R; Vasiljevic A; Lasolle H; Ducray F; Raverot G; Jouanneau E
Front Endocrinol (Lausanne); 2022; 13():882381. PubMed ID: 35757402
[TBL] [Abstract][Full Text] [Related]
30. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.
Gomes CC; de Sousa SF; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Mar; 127(3):231-236. PubMed ID: 30598409
[TBL] [Abstract][Full Text] [Related]
31. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].
Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
[No Abstract] [Full Text] [Related]
32. The Expanding Spectrum of Disease Treated by the Transnasal, Transsphenoidal Microscopic and Endoscopic Anterior Skull Base Approach: A Single-Center Experience 2008-2015.
Cote DJ; Wiemann R; Smith TR; Dunn IF; Al-Mefty O; Laws ER
World Neurosurg; 2015 Oct; 84(4):899-905. PubMed ID: 26008142
[TBL] [Abstract][Full Text] [Related]
33. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
Asa SL; Mete O; Ezzat S
Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
[TBL] [Abstract][Full Text] [Related]
34. Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.
Bi WL; Greenwald NF; Ramkissoon SH; Abedalthagafi M; Coy SM; Ligon KL; Mei Y; MacConaill L; Ducar M; Min L; Santagata S; Kaiser UB; Beroukhim R; Laws ER; Dunn IF
Endocrinology; 2017 Jul; 158(7):2284-2291. PubMed ID: 28486603
[TBL] [Abstract][Full Text] [Related]
35. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
36. [The 2017 WHO classification of pituitary tumors].
Saeger W
Pathologe; 2021 May; 42(3):333-351. PubMed ID: 33877399
[TBL] [Abstract][Full Text] [Related]
37. WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.
Sahm F; Reuss DE; Giannini C
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):163-171. PubMed ID: 28295484
[TBL] [Abstract][Full Text] [Related]
38. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
39. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
Peyre M; Feuvret L; Sanson M; Navarro S; Boch AL; Loiseau H; Kalamarides M
J Neurooncol; 2017 Jul; 133(3):633-639. PubMed ID: 28536991
[TBL] [Abstract][Full Text] [Related]
40. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.
Lopes MBS
Acta Neuropathol; 2017 Oct; 134(4):521-535. PubMed ID: 28821944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
